Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males

Abstract Insulin aspart (IAsp) is one of the main therapies used to control blood glucose after a meal. This study aimed to compare the pharmacokinetics (PK) and pharmacodynamics (PD) of 2 rapid-acting IAsp products: a new IAsp biosimilar (RD10046) and NovoRapid. In a single-center, randomized, sing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hui Liu, Hongling Yu, Lisi Sun, Jingtao Qiao, Sainan Wai, Shuang Li, Jiaqi Li, Huiwen Tan, Yerong Yu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b9a0825201e5476e81ccc868c6a633d2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!